|
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
|
5R01CA182969-04
|
$314,363
|
|
HUDSON, LAURIE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-04
|
$309,257
|
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-02
|
$656,491
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
1F31CA213901-01A1
|
$44,044
|
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-04
|
$3,481,450
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-03
|
$332,363
|
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
VEGF signaling in Mammary Tumorigenesis
|
2R01CA168464-06
|
$397,813
|
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-02
|
$38,596
|
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
5UH2CA206124-02
|
$248,101
|
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics
|
5R33CA177333-04
|
$298,354
|
|
FEDERSPIEL, MARK
|
MAYO CLINIC ROCHESTER
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-02
|
$390,115
|
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
1R01CA217625-01
|
$646,803
|
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UW Radiological Sciences Training Program
|
5T32CA009206-39
|
$488,926
|
|
HALL, TIMOTHY
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
1R01CA210259-01A1
|
$682,639
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
1R21CA216756-01
|
$187,050
|
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-02
|
$953,081
|
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness
|
5R21CA201865-02
|
$179,438
|
|
LIANG, GANGNING
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
|
5R01CA190642-03
|
$436,922
|
|
BASELGA, JOSE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
|
5R21CA208609-02
|
$174,000
|
|
PATEL, SAPNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Michigan Surgical Oncology Research Training Program
|
5T32CA009672-27
|
$206,509
|
|
ZOU, WEIPING
|
UNIVERSITY OF MICHIGAN
|
|
Understanding Uncertainties in Radiomics Studies
|
1R21CA216572-01
|
$174,000
|
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Understanding the consequences of oncogenic mutations on FGFR signaling
|
1F31CA216915-01
|
$44,044
|
|
RYAN, MOLLY
|
YALE UNIVERSITY
|
|
Understanding How Breast Cancers Activate and Respond to the Systemic Environment
|
5R01CA166284-06
|
$356,692
|
|
MCALLISTER, SANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Understanding barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer
|
5K23CA212272-02
|
$143,543
|
|
CARY, KELLY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Uncovering Gene Expression Differences between Benign and Premalignant Colorectal Polyps
|
1R21CA208461-01A1
|
$219,902
|
|
VILAR-SANCHEZ, EDUARDO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-04
|
$1
|
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis Network
|
5U24CA210990-02
|
$452,649
|
|
STUART, JOSHUA
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-03
|
$352,275
|
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
Tumor-initiating processes in luminal breast cancers
|
1F32CA213794-01A1
|
$56,694
|
|
SELDIN, LINDSEY
|
VANDERBILT UNIVERSITY
|
|
Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
|
5F31CA196329-02
|
$31,376
|
|
NASCIMENTO, ALDO
|
UNIVERSITY OF VIRGINIA
|
|
Tumor subtypes and therapy response in pancreatic cancer
|
5R01CA199064-02
|
$600,010
|
|
YEH, JEN JEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
5F31CA183493-04
|
$49,044
|
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Tubulin microtentacles in detached mammary epithelial cells
|
5R01CA124704-08
|
$295,632
|
|
MARTIN, STUART
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
|
5R01CA176624-04
|
$372,463
|
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Trithorax-related, MLL3 and MLL4 in enhancer-mediated cancer pathogenesis
|
5R00CA181506-04
|
$237,671
|
|
HERZ, HANS-MARTIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Triggering the dopamine pathway to inhibit lung cancer progression
|
5R00CA187035-04
|
$249,000
|
|
HOEPPNER, LUKE
|
UNIVERSITY OF MINNESOTA
|
|
TREM-1 and Its Implications to Cancer
|
5R01CA172230-04
|
$315,400
|
|
HORUZSKO, ANATOLIJ
|
AUGUSTA UNIVERSITY
|
|
Treatment of Refractory Nausea
|
5R01CA200579-02
|
$215,985
|
|
ROSCOE, JOSEPH
|
UNIVERSITY OF ROCHESTER
|
|
Treatment decision making in low-risk thyroid cancer
|
5R01CA201198-02
|
$759,437
|
|
HAYMART, MEGAN
|
UNIVERSITY OF MICHIGAN
|
|
Translational Research in Surgical Oncology
|
5T32CA093245-12
|
$441,040
|
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-05
|
$2,251,410
|
$135,085
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Physician-Scientist Training Program in Oncology
|
5T32CA160040-05
|
$242,661
|
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
Translational control of EMT by the CELF1 RNA Binding Protein
|
5R01CA190467-03
|
$362,569
|
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translating Molecular Diagnostics for Cervical Cancer Prevention into Practice
|
5R01CA190366-02
|
$532,648
|
|
GRAVITT, PATTI
|
GEORGE WASHINGTON UNIVERSITY
|
|
Training Program in Biostatistics for Cancer Research
|
5T32CA096520-13
|
$265,841
|
|
VANNUCCI, MARINA
|
RICE UNIVERSITY
|
|
Training of Surgeons for Studies of the Tumor Microenvironment
|
5T32CA200561-03
|
$277,522
|
|
MICHLER, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Training in Molecular& Genetic Epidemiology of Cancer
|
5R25CA112355-13
|
$525,610
|
|
WITTE, JOHN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Training in Cancer Therapeutics Research
|
5T32CA193205-03
|
$289,431
|
|
CHU, EDWARD
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Training Grant in Quantitative Sciences for Cancer Research
|
5T32CA009337-37
|
$533,725
|
|
PARMIGIANI, GIOVANNI
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
Total relevant funding to Gene Therapy Clinical Trials for this search: $6,543,370
|